Tech Company Financing Transactions

NeuCyte Funding Round

Cowin Venture Capital, Leaguer Ventures and private investors participated in a $6.7 million Series A funding round for NeuCyte. This venture round was announced on 5/9/2018.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1561 Industrial Rd.
San Carlos, CA 94070
USA

Phone

650-274-8199

Website

www.neucyte.com

Email Address

[email protected]

Overview

The high attrition rates of novel CNS drugs in clinical trials is a clear indication that current drug discovery paradigms are failing to serve the unmet needs of millions of patients. Our mission is to improve the lives of these individuals by developing better translatable assays to accelerate and optimize CNS drug discovery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tao Huang

        

Chief Scientific Officer

Daniel Haag

        

VP - Operations

Ji Wu

        

VP - R & D

Thomas Portman

        

Browse more venture capital transactions:

Prev: 5/8/2018: Brightside venture capital transaction
Next: 5/9/2018: BorderX Lab venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary